ShareValue scores for SAIPARENT.NSE: Valuation 29, Quality 47, Growth 50, Health 51.

SAIPARENT.NSE
NSE

SAIPARENT

₹540.85(-0.47%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-6% to 10%
Valuation
29
Overvalued
Price vs Value
Quality
47
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
51
Moderate
Financial Stability
Momentum
36
Bearish
Price Trend

Company Details

About

Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally. Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, oncology, and dermatology in various dosage forms, including injectables, solid orals, liquid orals, and topicals. The company was founded in 1988 and is based in Hyderabad, India. Address:

Score Analysis

AI Investment Thesis

Data as of:Aug 25, 2026
|
Last calculated:Aug 25, 2026